JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - SGD (hedged)

WKN A2PR4B | ISIN LU2053354986 |  Fonds
Factsheet
03.04.25
8,41 SGD-0,59 % (-0,05)

Fonds

ISIN Name Performance Volatilität Sharpe Ratio
1 BE0170813936 KBC Equity Fund Medical Technologies Classic +6,99 % +11,29 % 0,41
2 LU2036818289 CPR Invest - MedTech - H USD - Acc +4,11 % +12,42 % 0,14
3 LU2418149048 UBS (Lux) Equity Fund - Sustainable Health Transformation (USD), Anteilsklasse F-acc, USD +3,60 % +12,46 % 0,10
4 LU0358044559 UBS (Lux) Equity Fund - Sustainable Health Transformation (USD), Anteilsklasse Q-acc, USD +3,31 % +12,45 % 0,08
5 LU2194372939 Bellevue Funds (Lux) - Bellevue Medtech & Services U2 USD - Accumulating +3,27 % +12,69 % 0,07
402 LU2053354986 JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - SGD (hedged) -20,36 % +21,29 % -1,07
439 LU2075272034 Schroder International Selection Fund Healthcare Innovation B Accumulation EUR Hedged -12,14 % +11,90 % -1,22
440 LU2387457729 Franklin Templeton Investment Funds Franklin Genomic Advancements Fund Klasse N (acc) EUR -21,04 % +19,04 % -1,23
441 LU2425425506 Candriam Equities L Oncology, V - Capitalisation -12,39 % +11,76 % -1,25
442 LU1864482515 Candriam Equities L Oncology, I - Capitalisation -12,67 % +11,76 % -1,28
443 LU1864482945 Candriam Equities L Oncology, R - Capitalisation -12,75 % +11,76 % -1,28